SCHEMBL14367355

SCHEMBL14367355

CN(C(=O)c1cc2nc(-c3ccccc3)cc(C(F)(F)F)n2n1)C1CCCCC1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.74
HSD17B10 Q99714 5/20 0.74
KMT2A Q03164 3/20 0.74
MEN1 O00255 2/20 0.74
MAPT P10636 1/20 0.74
ALOX15 P16050 1/20 0.74
BLM P54132 1/20 0.74
KDM4E B2RXH2 7/20 0.66
ALDH1A1 P00352 6/20 0.66
SMN1; SMN2 Q16637 4/20 0.66
LMNA P02545 1/20 0.60
RAB9A P51151 2/20 0.57
TP53 P04637 3/20 0.57
MAPK1 P28482 1/20 0.57
POLB P06746 1/20 0.54
THRB P10828 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
CASP1 P29466 1/20 0.53
CASP7 P55210 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4206614 0.88 KDM4E (0.62) HPGDHSD17B10KMT2AMEN1MAPT
SCHEMBL1718468 0.87 HSD17B10 (0.65) HPGDHSD17B10KMT2AMEN1MAPT
SCHEMBL4204727 0.87 KDM4E (0.62) HPGDHSD17B10KMT2AMEN1MAPT
SCHEMBL4208969 0.86 HPGD (0.68) HPGDHSD17B10KMT2AMEN1MAPT
SCHEMBL1719321 0.85 HPGD (0.69) HPGDHSD17B10KMT2AMEN1MAPT
SCHEMBL4210311 0.83 HPGD (0.67) HPGDHSD17B10KMT2AMEN1MAPT
SCHEMBL4204328 0.83 HPGD (0.57) HPGDHSD17B10KMT2AMEN1MAPT
SCHEMBL1718813 0.81 KDM4E (0.74) HPGDHSD17B10KMT2AMEN1MAPT
SCHEMBL16615203 0.80 KDM4E (0.67) HPGDHSD17B10KMT2AMEN1MAPT
SCHEMBL1718188 0.80 ALDH1A1 (0.78) HPGDHSD17B10KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines NOVO NORDISK A/S (DK) 2007-11-22 US disclosed
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines NOVO NORDISK A/S (DK) 2007-11-22 US disclosed
EP-1782859-A2 Pharmaceutical use of substituted pyrazolo [1,5- a]pyrimidines NOVO NORDISK A/S (DK) 2007-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines HSD3B1, HSD11B1, SRD5A1 HPGD 24/4885HSD17B10 44/4885KMT2A 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.